San Francisco, CA – Loyal, a first-of-its-kind anti-aging drug in the works to extend the life of dogs, has reached a key milestone: senior dogs across the U.S. are taking the pill as part of a clinical trial.
Boo, an 11-year-old whippet from Pennsylvania who competes in a dog sport called scent work, is the trial’s first participant.
Loyal developers say the large-scale clinical trial, called the STAY study, will include more than 1,000 dogs from over 50 veterinary clinics across the U.S.
Source: fox35orlando.com
